DASHpharma offers those parent companies who have recently acquired, licensed or developed a product/technology for the UK and European hospital market the opportunity to rapidly and effectively penetrate the market. DASHpharma's may assist and supplement new product marketing by utilizing experience and contacts to carry out market research, place clinical trials, develop protocols and arrange symposia and conferences. DASHpharma can assist with product and clinical training and work synergistically with the parent's sales force or if preferred DASHpharma will provide a single contract sales force for an agreed period of time.

Individual brands or therapy groups that parent companies no longer promote provide cash generation through a declining life cycle. Increasingly, pharmaceutical companies are faced with investing large promotional resource behind the major brands at the expense of smaller turnover less strategically important products. DASHpharma offers companies the option of contracting out the promotion of these brands through a range of bespoke commercial agreements.

Graph: Demonstrating extra revenue generated by promoting orphan brand(s)

DASHpharma can offer a gain share solution, whereby for a management fee at actual cost to ourselves, we will promote the brand(s) and an agreed rate of decline/increase of sales and margin would be determined. The difference between the current company projections of sales and profit declination/increase and NPV and that achieved by DASHpharma promotion, would be shared between the two companies in an agreed ratio. This ratio would always ensure that the parent company would return it's management fee investment before the excess profit/incentive was split. DASHpharma's profit can only come from performance driven incentive. Theoretical examples are shown.

Table: Theoretical Example

Graph: Demonstrating gain share profit incentives between DASHpharma and parent company

The benefits of this contract strategy to the parent are:

European Marketing Agents/Partners